[ Price : $8.95]
Intellia Therapeutics starts a rolling BLA submission for its experimental gene-editing therapy lonvoguran ziclumeran, or lonvo-z,...[ Price : $8.95]
FDA identifies significant deficiencies at BayCare Integrated Service Center, an outsourcing facility in Temple Terrace, FL, follo...[ Price : $8.95]
FDA accepts for priority review a Jazz Pharmaceuticals supplemental BLA for Ziihera (zanidatamab-hrii) for use in combination regi...[ Price : $8.95]
A federal judge dismisses a lawsuit brought by homeopathy advocates and a product distributor challenging FDAs decision to tighten...[ Price : $8.95]
Concerns that political pressure could undermine the U.S. drug approval system intensify this week after a new White House directi...[ Price : $8.95]
FDA announces several actions aimed at accelerating the development of treatments for serious mental illness, following a recent e...[ Price : $8.95]
A recent FDA Warning Letter signals a broader regulatory focus on how drugmakers use artificial intelligence, according to a new a...[ Price : $8.95]
FDA issues AbbVie a complete response letter for its BLA for trenibotulinumtoxinE, an investigational, fast-acting botulinum toxin...